Background-Impaired renal function after coronary artery bypass graft (CABG) surgery is a key risk factor for in-hospital mortality. However, perioperative increases in serum creatinine and the association with mortality has not been well-studied.
A cute renal failure (ARF) is a common and lethal outcome after coronary artery bypass graft (CABG) surgery. Patients with ARF in the intensive care unit have a 50% to 70% risk of death. 1 Among CABG patients, 30% to 50% without preoperative renal failure develop ARF within 2 days after the surgery and have been shown to have a 60% increased risk of mortality. 2, 3 ARF has been independently associated with high mortality, 3, 4 especially in-hospital mortality. 2, [5] [6] [7] [8] Elevations in serum creatinine (Cr) have been a commonly used marker of ARF in hospitalized patients. However, many methods have been used to characterize ARF including preoperative Cr, 9, 10 postoperative Cr, the absolute increase from preoperative Cr to the highest postoperative level, or the relative percent increase from preoperative to postoperative Cr (%⌬Cr). The definition of ARF has varied widely, ie, %⌬Crϭ20%, 6,11 25%, 8, 12 30%, 7 or 50%. 3, 7 Studies demonstrated their definition of ARF (ie, %⌬Cr) was associated with in-hospital mortality after CABG. However, little has been shown with regard to survival after hospitalization. One long-term survival study demonstrated higher preoperative levels of Cr were associated with 1-year mortality, 13 confirming the high risk of mortality for patients with preoperative renal failure. 14 A similar study examined survival by dividing patients into groups by the absolute change from preoperative Cr to postoperative Cr, showing higher absolute changes in Cr were associated with higher 3-year mortality. 15 One study examined the relative effect of %⌬Cr on long-term mortality; however, this study only assessed the survival for patients discharged alive, stratified patients into 1 of 2 groups of %⌬Cr (Ͻ25% and Ն25%⌬Cr) and showed patients with a Ն25%⌬Cr had slightly higher 8-year mortality. 8 Although the difference was significant, the magnitude of the effect was not substantial.
To date, the literature does not examine the effect of differing levels of percent increases in Cr (%⌬Cr) on longer-term mortality. In this study, we examined stratified levels of %⌬Cr with respect to 90-day mortality. We hypothesized that a 25% to 49%, 50% to 99%, Ն100%⌬Cr at 48 hours after CABG surgery would exhibit a sequential increase in 90-day mortality.
Methods
The Northern New England Cardiovascular Disease Study Group (NNECDSG) was founded in 1987 as a regional voluntary consortium capturing 100% of the coronary revascularizations and/or valve procedures in northern New England including 8 medical centers in Vermont, New Hampshire, and Maine. The group consists of clinicians, hospital administrators, and health care research personnel who seek to improve continually the quality, safety, effectiveness, and cost of medical interventions in cardiovascular disease. The NNECDSG has Institutional Review Board approval for data collection and analysis at all participating centers. The authors had full access to the data and take full responsibility for their integrity. All authors have read and agree to the manuscript as written.
We prospectively enrolled 1412 CABG procedures at participating NNECDSG centers between January 2001 and December 2001 and obtained preoperative and postoperative serum creatinine measure-ments (mg/dL). Twenty-one patients with preoperative renal failure requiring dialysis were excluded from the analysis, leaving 1391 patients that contributed to this analysis. We excluded patients undergoing CABG occurring with heart valve repair or replacement, resection of ventricular aneurysm, or another surgical procedure.
Data Collection
The following data were recorded prospectively for all patients. Preoperative characteristics: age, sex, height, weight, body surface area, hypertension, chronic obstructive pulmonary disease, preoperative use of an intra-aortic balloon pump (IABP), and preoperative renal failure requiring dialysis (hemodialysis, peritoneal dialysis). Last preoperative serum creatinine (mg/dL) and highest postoperative creatinine (highest for postoperative index admission) were documented. Methods for data collection and definitions for these variables have been described previously. 14 Percent change in serum creatinine (%⌬Cr) was calculated by: [[(highest postoperative Cr)/(last preoperative Cr)]Ϫ1] ϫ 100%. The percent change values were divided into 4 groups: Ͻ 25%, 25% to 49%, 50% to 99%, Ն100%. These groups were based on previous studies that define ARF as 25% 8, 12 or 50% 3,7,16 increase in serum creatinine. Relative verses absolute effects were compared using terciles of baseline Cr. Terciles (T1, T2, T3) were generated for each %⌬Cr group: T1 Cr Յ0.9, T2 0.9 to 1.2, T3 Ͼ1.2 (mg/dL).
Patient Follow-Up
The primary outcome of this analysis was all-cause mortality at 90 days. Mortality was determined by a match of the NNECDSG regional registry to the National Death Index (US Department of Health and Human Services) 17 using name, social security number, date of birth, sex, date last known alive, and state of last known residence. 
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Statistical Analysis
Baseline characteristics and clinical outcomes were summarized by percentages and means (Ϯstandard deviation). We used 2 tests and tests of trend to assess similarities between categories of %⌬Cr. Kaplan-Meier techniques were used to conduct the survival analysis; patients were stratified by %⌬Cr from baseline: Ͻ25%, 25% to 49%, 50% to 99%, Ն100%. Incidence of death (deaths per 10 000 person-days) was calculated for each category. Cox's proportional hazard models were used to calculate crude and adjusted hazard ratios (HR): Ͻ25% as referent, adjusting for age and sex. Adjusted HRs were reported with 95% confidence intervals and subsequent probability values. Relative verses absolute effects for %⌬Cr and baseline Cr were compared graphically, using Kaplan-Meier and log-rank methods. Analyses were conducted using Stata 9.0 (Stata, College Station, TX).
Results

Patient Characteristics
Patients were divided into 4 groups based on %⌬Cr. Patient baseline characteristics are reported in Table 1 . Age and female sex were significantly higher across %⌬Cr groups. More patients had chronic obstructive pulmonary disease and diabetes in the higher %⌬Cr groups. Body surface area, hypertension, PVD, and preoperative serum creatinine (mg/dL) were similar across all groups. Patients across the categories had similar left main disease and previous CABG surgery. Differences were noted across all groups with respect to unstable angina, number of diseased vessels, ejection fraction, and LVEDP.
Survival Analysis
Patients were followed-up prospectively and linked to the National Death Index with 102 129 person-days of follow-up and 54 deaths ( Table 2 ). The 90-day incidence of death (per 10 000 person-days of follow-up) for Ͻ25% (2.0), 25% to 49% (4.2), 50% to 99% (18.0), and Ն100% (54.6). Each increase in %⌬Cr category had a higher 90-day death rate and adjusted HR for each %⌬Cr category ( Table 3 ). The Kaplan-Meier survival plot demonstrates an increased 90-day mortality for patients with a 50% to 99% and Ն 100%⌬Cr ( Figure  1 ). The survival curves for 50% to 99% and Ն100%⌬Cr were significantly different at PϽ0.001, as calculated by a log-rank test, suggesting a 50% or greater %⌬Cr results in worse 90-day survival. We repeated our analysis adjusting for baseline creatinine and perioperative factors (clamptime, pumptime, IABP and inotrope use, perioperative myocardial infarction, and stroke), which showed no difference in the reported findings. All interactions were assessed and ruled out.
We examined the relative (%⌬Cr) effect compared with the absolute (terciles of baseline Cr) for our analysis ( Figure   2 ). We found patients in all 3 terciles of baseline Cr with Ͻ50%⌬Cr did not have different incidence of death (per 10 000 person-days) within their respective %⌬Cr group. However, patients in the higher risk %⌬Cr groups (Ն50%⌬Cr) showed an increase in cumulative incidence across terciles of baseline Cr; this trend within each tercile was consistent with the survival curves ( Figure 1 ).
Clinical Outcomes
Patients with a Ն50%⌬Cr or more were more likely to have worse outcomes (Table 4) ; there was a significant association with an increase in poor outcome with increasing category of %⌬Cr. Patients with Ն50%⌬Cr were more likely to have low cardiac output, atrial fibrillation, hypotension, and infection (mediastinitis and/or pneumonia). These outcomes identify an association with %⌬Cr and renal injury; such outcomes may of have been caused by renal hypoperfusion as a result of cardiopulmonary bypass, circulating toxins, increase in inflammation or perioperative hypotension. Hypotension and inflammatory mediators may cause the increase in creatinine resulting in renal damage and increased risk of mortality. Inflammation may be a factor for the onset of atrial fibrillation as noted with a more than a doubling of atrial fibrillation rates from the lowest to highest creatinine groups. 18
Discussion
We examined 90-day mortality associated with %⌬Cr. We found Ն50%⌬Cr was associated with increased 90-day mortality verses patients experiencing Ͻ25%⌬Cr. Patients with a doubling of serum creatinine (Ն100%⌬Cr) during the perioperative period experienced the highest 90-day mortality. This finding suggests a patient with more than a doubled creatinine (preoperative to postoperative) has a 22-fold increased risk of dying within 90 days after CABG surgery. A patient with 50% to 99%⌬Cr has a 7-fold increased risk of dying within 90 days. Strikingly, patients with 25% to 49%⌬Cr were no different from patients with Ͻ25%⌬Cr.
These findings were consistent with other clinical outcomes and suggests acute renal failure should be diagnosed when there is Ն50%⌬Cr and not at 20%, 6,11 25%, 8, 12 or 30%. 7 Our results are consistent with Lassnigg et al, who report a 0.5 (mg/dL) change in creatinine from preoperation to postoperation was indicative of acute renal failure and associated with an 18-fold risk of 30-day mortality, with no significant risk of mortality after 30 days (HR, 5.76). 15 In our study we used a percent increase in serum creatinine, thereby using each patient as his/her own control relative to their baseline serum creatinine. We also report 90-day survival with more strata of %⌬Cr exposure portraying a more accurate picture of the association between %⌬Cr and 90-day mortality. Our analysis was consistent with Loef et al, who report survival relative to 2 exposure groups of serum creatinine: Ͻ25% and Ͼ25%. 8 Patients alive at discharge with Ն25%⌬Cr had slightly higher mortality to patients with Ͻ25%⌬Cr, and although the difference was significant, the magnitude of the effect was not substantial. 8 Our findings were consistent with this study in which Ͻ25% and 25% to 49%⌬Cr groups had similar 90-day survival. We expanded on this analysis by providing 2 additional strata of creatinine exposure (50% to 99%, and Ն100%⌬Cr) and reported survival outcomes for all isolated CABG patients regardless of discharge status.
In-hospital mortality has been associated with high preoperative Cr, 6 postoperative Cr, 19 preoperative-to-postoperative increases in Cr, 4 and %⌬Cr. 3, 7, 11, 20 Conlon et al showed an increase in Cr by 1.0 (mg/dL) and new onset of renal failure was associated with mortality. 4 We chose rather to calculate the %⌬Cr, categorize patients into 4 groups and assessed 90-day mortality. Our analysis includes in-hospital deaths in the 90-day mortality and is in agreement with other reports showing that %⌬Cr is associated with mortality. 3, 7, 11 However, our results proved a Ͻ50%⌬Cr was not associated with an increased risk of 90-day mortality; this is in agreement with the reports favoring at least a 50%⌬Cr as a predictor of early mortality. 3, 7 We add to their analysis of early mortality with the addition of four categories of %⌬Cr and extend the mortality assessment to 90-days to suggest patients with a 50% or 100%⌬Cr are at increased risk of 90-day mortality.
The mechanism of acute renal failure likely involves hypotension, nephrotoxins, and fluid overloading. Thadhani et al reported renal tubular necrosis accounts for 85% of acute renal failure (50% ischemia, 35% toxins). 21 This finding is likely similar in CABG surgical patients as well, whereby hypotension could result from low cardiac output or low pressure from the cardiopulmonary pump. Nephrotoxins may include drugs and contrast dye from a preoperative catheterization among urgent surgical patients. Furthermore, we discovered distinct associations between patients with elevated %⌬Cr and low output syndrome and infection; these associations may suggest these clinical manifestations present prior to elevations in serum creatinine, result in damage to the kidney followed by an increase in creatinine. Therefore, hypotension, nephrotoxins, and inflammation may lead to acute renal failure observed as a substantial (Ն50%) increase in serum creatinine. There are several limitations to this study. We prospectively enrolled patients in this study as part of the NNECDSG regional registry cohort, which collects and reports data on 100% of the cardiac procedures in northern New England. Therefore, biases resulting from patient enrollment or data collection are not valid limitations of this study. We noted several baseline differences in patients across the creatinine categories. We were limited by the number of risk factors we could adjust for based on only 54 deaths. Because of this limitation we only report age-and sex-adjusted HRs. However, the unadjusted and age/sexadjusted HRs did not differ, nor did the HRs differ after adjusting for multiple risk factors. We can only speculate these risk factors were not confounding our results; however, a larger cohort will be required to adequately assess these risk factors in the future. Our findings are limited to 1 year and 90-day mortality. The NNECDSG registry is ongoing and will conduct a 4-to 5-year follow-up analysis on the same categories of %⌬Cr in the near future with updated NDI data.
We need to recognize that patients with a 50%⌬Cr are at risk for mortality and act in response to elevations in %⌬Cr to avoid hypotension, nephrotoxins, and fluid overloading. Several interventional trials have examined treatments that may prevent damage to the kidneys during the perioperative course. 16, 22, 23 In the interim, we must consolidate our findings to define acute renal failure at established cut-off values for %⌬Cr for rapid identification of patients at risk. Our results are consistent with that of Chertow et al 3 and Provenchere et al, 7 reporting a 50%⌬Cr or greater is associated with a higher risk of death after CABG surgery.
In summary, our findings demonstrate the pernicious effects of %⌬Cr on 90-day survival. Patients with Ն50%⌬Cr have an increased risk of dying within 90 days compared with patients with Ͻ25%⌬Cr. Patients with a 25% to 49%⌬Cr are at low risk and do not differ with regard to 90-day survival to those with Ͻ25%⌬Cr; this is important to note because others have reported small percent increases in creatinine (20% to 30%⌬Cr) have been associated with an increased risk of mortality. Our results showed patients with both low (baseline Cr Ͻ0.5 mg/dL) and high (baseline Cr Ͼ2.0 mg/dL) Cr populate all 4 categories of %⌬Cr. Therefore, we conclude all patients are susceptible to %⌬Cr. Reasonable clinical responses to %⌬Cr should include avoiding hypotension and nephrotoxic drugs. Efforts should be taken to identify patients at risk of renal injury before surgery.
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